Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.50
Bid: 48.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.083%)
Open: 48.50
High: 49.00
Low: 48.50
Prev. Close: 48.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

25 Apr 2016 14:00

RNS Number : 1931W
Cambridge Cognition Holdings PLC
25 April 2016
 

25 April 2016

 

Cambridge Cognition Holdings Plc

("Cambridge Cognition" or the "Company")

 

Director Dealing

 

 

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in development and marketing of computerised neuropsychological tests including those enabling the early detection of dementia, announces that certain Directors of the Company, being Michael Lewis, Steven Powell and Nick Walters, have today subscribed for Ordinary Shares respectively at a price of 37 pence per Ordinary Share, as part of the Company's previously announced Placing.

 

On Admission of the Placing Shares, Michael Lewis, Steven Powell and Nick Walters will have the following interests in the Company:

 

Director

Number of Placing Shares subscribed for

Number of Ordinary Shares held on Admission

Percentage of Ordinary Shares held on Admission

Michael Lewis

5,406

33,375

0.16%

Steven Powell

40,541

40,541

0.20%

Nick Walters

67,568

186,937

0.92%

 

All capitalised but undefined terms in this announcement shall have the meaning ascribed to them in the Company's announcement of 25 April 2016 in relation to, inter alia, the Placing.

 

 

Enquiries:

 

Cambridge Cognition Holdings plc

www.cambridgecognition.com

Steven Powell, Chief Executive Officer

Tel: 01223 810 700

Nick Walters, Chief Financial Officer

finnCap Ltd (Nomad & Joint Broker)

Tel: 020 7220 0500

Geoff Nash / Simon Hicks

(Corporate Finance)

Alice Lane

(Corporate Broking)

Hybridan LLP (Joint Broker)

Tel: 020 3764 2341

Claire Noyce

(Corporate Broking)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHVELBLQZFFBBB
Date   Source Headline
25th Nov 20197:00 amRNSCambridge Cognition expands eCOA and wins contract
31st Oct 20194:17 pmRNSGrant of Options
29th Oct 20197:00 amRNSHolding(s) in Company
25th Oct 20197:00 amRNSAlzheimer's drug potential for Cambridge Cognition
26th Sep 201912:15 pmRNSDirector/PDMR Shareholding
23rd Sep 201910:42 amRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSInterim Results
30th Aug 20194:59 pmRNSHolding(s) in Company
29th Aug 20192:20 pmRNSHolding(s) in Company
27th Aug 20197:00 amRNSTrading Update
14th Aug 201910:10 amRNSDr. Nick Kerton
12th Aug 20197:00 amRNSExpansion in Chinese market
22nd Jul 20197:00 amRNSNotice of Results
19th Jul 20197:00 amRNSNew Commercial Partnership for NeuroVocalix
1st Jul 20197:00 amRNSAppointment of Non-Executive Director
11th Jun 20197:00 amRNSCapital Markets Day
23rd May 20192:35 pmRNSResult of AGM and Board Changes
1st May 20197:00 amRNSPosting of Annual Report & Notice of AGM
25th Apr 20197:00 amRNSBoard Changes
17th Apr 20197:00 amRNSGrant of Options
19th Mar 20197:00 amRNS£1.3m digital health contract win
14th Mar 20198:54 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSHolding(s) in Company
12th Mar 20195:23 pmRNSDirector/PDMR Shareholding
12th Mar 201911:59 amRNSHolding(s) in Company
7th Mar 20197:02 amRNSAppointment of Chief Operating Officer
7th Mar 20197:01 amRNSFundraising to raise £2.5 million
7th Mar 20197:00 amRNSPreliminary Results
31st Jan 20197:00 amRNSFirst Partnership in India and New Product Launch
19th Dec 20187:00 amRNSTrading update and notice of results
14th Nov 20187:00 amRNSContract win in growing eCOA revenue stream
20th Sep 20187:00 amRNSHalf Yearly Report
19th Sep 20187:00 amRNSCompany signs first NeuroVocalix contract
13th Sep 20187:00 amRNSNeuroVocalixT platform ready for clinical trials
1st Aug 20187:00 amRNSCANTAB incorporated in population health platform
20th Jun 20187:00 amRNSNew product to improve workplace mental health
7th Jun 20187:00 amRNSPartnership to tackle growing mental health need
31st May 20187:00 amRNSNew client signs with Cognition Kit software
24th May 201812:24 pmRNSResult of AGM
9th May 201811:34 amRNSHolding(s) in Company
3rd May 20187:00 amRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNSPosting of Annual Report & Notice of AGM
12th Apr 20181:20 pmRNSHolding(s) in Company
12th Apr 201810:20 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSRecruitment contracts show strong growth
26th Mar 20187:00 amRNSMajor Contract Win and Funding Award
22nd Mar 201811:05 amRNSSecond Price Monitoring Extn
22nd Mar 201811:00 amRNSPrice Monitoring Extension
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.